Down Syndrome clinical trials at UCSD
2 research studies open to eligible people
open to eligible people ages 25 years and up
This is an observational, multi-center, longitudinal cohort study to characterize adults with DS ages 25 years and above enrolled at specialized care centers. The aim is to assess changes in cognition, behavior, function and health over approximately 32 months. Blood will be collected for the development of plasma AD biomarkers useful in the DS population.
La Jolla, California and other locations
open to eligible females ages 18 years and up
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
San Diego, California and other locations
Our lead scientists for Down Syndrome research studies include Andrew Hull, MD.